News BriefsScience & Research

Report: Psychedelics Could Prove Too Subjective for Pharmaceutical Formulas

A paper, “The shifting fortunes of corporate psychedelia,” published in the September issue of Cambridge’s Finance and Society, suggests that the “unruliness [of] psychedelics as assets” could severely limit the capitalization of for-profit psychedelic medicines. Published by Dr. Sandy Brian Hager, Reader in International Political Economy at City St George’s, University of London, the research […]